insights from industryBernd GleixnerDivision President AutomationBruker Biopsin News Medical speaks to Bernd Gleixner, Division President Automation at Bruker Biospin, about the future of lab ...

Employee burnout rates in the healthcare sector were exceptionally high even before COVID-19. Burnout has a significant adverse influence on clinicians’ overall well-being, as well as their sense of ...

Are you working for your data or are your data working for you? Over the last decade or so, labs have made the move from paper lab notebooks to digital laboratory platforms (DLPs). This is a great ...

Automation can offer labs a vast range of benefits, from improving productivity and accuracy to enabling researchers to focus on less menial tasks. Despite this potential, many labs are hesitant to ...

NewsMedical talks to Bruker BioSpin about how Chemspeed’s modular automation systems integrate with NMR technology to enable smarter, more autonomous labs. Chemspeed systems are known for their ...

Every stage of biopharma drug development depends on what happens in the laboratory. Consequently, any one of these stages—which include target identification, lead optimization, candidate screening, ...

Labroots is delighted to host the 9th Annual Event in the Laboratory Automation Virtual Event Series, scheduled on March 19th, 2025! Dive into the cutting edge of laboratory technology at this free ...

The progress in laboratory automation could be one of the most consistent changes in research in the life sciences and biomedicine over the past 30 years. The evolution of this field borders on the ...

The lab automation market is expected to surpass $8.36 billion globally in 2025 and reach $14.78 billion by 2034. Pharmaceutical and biotech companies are making huge investments in lab automation ...